Study finds 5-year relative survival rate of 59.6 percent in lower-risk myelodysplastic syndromes
by Elana Gotkine HealthDay ReporterAbout 40 percent of patients with lower-risk myelodysplastic syndromes (LR-MDS) die of MDS within five years, according to a study published online Nov. 6 in the&nbs
Updated on: January 23,2024
14

Study finds 5-year relative survival rate of 59.6 percent in lower-risk myelodysplastic syndromes
by Elana Gotkine HealthDay ReporterAbout 40 percent of patients with lower-risk myelodysplastic syndromes (LR-MDS) die of MDS within five years, according to a study published online Nov. 6 in the&nbs
Updated on:January 23,2024
14
